169 related articles for article (PubMed ID: 1669886)
1. Responsiveness to intradermal recombinant hepatitis B vaccine.
CDR (Lond Engl Wkly); 1991 Oct; 1(43):198. PubMed ID: 1669886
[No Abstract] [Full Text] [Related]
2. Low response to hepatitis B virus vaccine in Costa Rican health-care workers.
Taylor L; García Z; Herrera G; Luftig RB; Visona KA
Hepatology; 1998 Feb; 27(2):637. PubMed ID: 9462669
[No Abstract] [Full Text] [Related]
3. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
Bauer H; Potasman I; Pick N
Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
[TBL] [Abstract][Full Text] [Related]
4. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
[TBL] [Abstract][Full Text] [Related]
6. [Comparative efficacy of intradermal and intramuscular active immunization against hepatitis B with a recombinant vaccine. Preliminary results].
Torres JR; de Marquez ML; Gonzalez A; Ramirez V; Martinez N; Lecuna V
G E N; 1993; 47(3):145-9. PubMed ID: 8112550
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
Ristola MA; Vuola JM; Valle M; von Reyn CF
Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
[TBL] [Abstract][Full Text] [Related]
9. Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B--United States, 1990-1991.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(33):569-72. PubMed ID: 1830921
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant hepatitis B vaccine in health personnel of the Peruvian Institute of Social Security].
Zumaeta E; Figueroa R; Ferrándiz J; González Griego A; Ramírez Albajés V
Rev Gastroenterol Peru; 1995; 15(2):135-9. PubMed ID: 7662916
[TBL] [Abstract][Full Text] [Related]
11. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of low-dose intradermal hepatitis B vaccination. Five years' experience of primary vaccination.
Thompson SC; Darlington R; Tallent D; Robins-Browne R; Forsyth JR
Med J Aust; 1993 Mar; 158(6):372-5. PubMed ID: 8479349
[TBL] [Abstract][Full Text] [Related]
13. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
[TBL] [Abstract][Full Text] [Related]
14. Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.
Marinho RT; Ramalho F; Velosa J
Hepatology; 1998 Oct; 28(4):1166. PubMed ID: 9841230
[No Abstract] [Full Text] [Related]
15. Seroconversion with rDNA hepatitis B vaccine of Cuban origin.
Kar P; Jandwani P; Khurana V; Kumar V; Gupta RK; Sama S; Wadhawan S
Indian J Gastroenterol; 1997 Oct; 16(4):161. PubMed ID: 9357198
[No Abstract] [Full Text] [Related]
16. Vaccination against hepatitis B: comparison of intradermal and intramuscular administration of plasma derived and recombinant vaccines.
Payton CD; Scarisbrick DA; Sikotra S; Flower AJ
Epidemiol Infect; 1993 Feb; 110(1):177-80. PubMed ID: 8432320
[TBL] [Abstract][Full Text] [Related]
17. Response to hepatitis B vaccination in high risk population.
Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
19. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
Sorkhi H; Dooki MR; Ebrahimnejad MS
J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants.
Rao MN; Joshi N; Habibullah CM
Indian Pediatr; 1999 Jun; 36(6):581-3. PubMed ID: 10736587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
